Prebiotics, Probiotics, and Gut Microbiota with Chronic Disease—2nd Edition
A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Prebiotics and Probiotics".
Deadline for manuscript submissions: 25 January 2025 | Viewed by 67
Special Issue Editor
Interests: gut microbiota; marine polysaccharides; colitis; inflammatory bowel disease; fermentation; prebiotics; probiotics; obesity; diabetes; carbohydrate-based drugs
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic diseases, including heart disease, stroke, cancer, type 2 diabetes, obesity, inflammatory bowel diseases, and arthritis are the leading causes of death and disability worldwide. Previous studies have demonstrated a pivotal role of gut microbiota in the pathogenesis of chronic diseases. However, we are still at the very beginning of understanding the complex interactions between gut microbiota and the development of chronic diseases. In this Special Issue of Nutrients, we sincerely invite you and your colleagues to submit research articles or informative reviews aiming to elucidate the complex interactions between gut microbiota and different chronic diseases. Specifically, we would like to understand how specific gut microbes work to contribute to or help to prevent the development of chronic diseases. Additionally, we would also like to advance our current understanding of the beneficial effects of prebiotic and probiotics on chronic diseases. Research articles and reviews to be considered for publication in this Special Issue of Nutrients should focus on the following topics:
- Use of prebiotic and probiotics for the prevention and treatment of chronic diseases;
- Pathogenetic gut bacteria that could contribute to the development of chronic diseases;
- Modulatory effects of prebiotic and probiotics on the dysbiotic microbiota of chronic diseases;
- Use of synbiotics and postbiotics for the prevention and treatment of chronic diseases;
- Development of live biotherapeutic products for the prevention and treatment of chronic diseases;
- Novel nutrition therapies that could be used for the prevention and treatment of chronic diseases by targeting gut microbiota;
- The effects of different gut bacterial metabolites on the development of chronic diseases;
- Fecal microbiota transplantation for the management of chronic diseases;
- Natural products that could be used for the treatment of chronic diseases by targeting gut dysbiosis.
Dr. Qingsen Shang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prebiotics
- probiotics
- synbiotics
- postbiotics
- microbiota
- chronic disease
- gut dysbiosis
- fecal microbiota transplantation
- gut bacterial metabolites
- live biotherapeutic products
- next-generation prebiotics
- next-generation probiotics
